96 related articles for article (PubMed ID: 25316315)
1. Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening.
Chen H; Knerr L; Åkerud T; Hallberg K; Öster L; Rohman M; Österlund K; Beisel HG; Olsson T; Brengdhal J; Sandmark J; Bodin C
Bioorg Med Chem Lett; 2014 Nov; 24(22):5251-5. PubMed ID: 25316315
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
Qiu S; Chen F; Liu Y; Lai L
Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel inhibitors of Daboia russelli phospholipase A2 using the combined pharmacophore modeling approach.
Ramakrishnan C; Joshi V; Joseph JM; Vishwanath BS; Velmurugan D
Chem Biol Drug Des; 2014 Oct; 84(4):379-92. PubMed ID: 24703201
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: Crystallographic, in silico docking and QSAR analysis.
Lokeshwari DM; Achutha DK; Srinivasan B; Shivalingegowda N; Krishnappagowda LN; Kariyappa AK
Bioorg Med Chem Lett; 2017 Aug; 27(16):3806-3811. PubMed ID: 28676270
[TBL] [Abstract][Full Text] [Related]
5. Ligand efficiency based approach for efficient virtual screening of compound libraries.
Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
[TBL] [Abstract][Full Text] [Related]
6. Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2.
Sivaramakrishnan V; Ilamathi M; Ghosh KS; Sathish S; Gowda TV; Vishwanath BS; Rangappa KS; Dhananjaya BL
J Mol Recognit; 2016 Jan; 29(1):22-32. PubMed ID: 26218369
[TBL] [Abstract][Full Text] [Related]
7. The discovery of novel β-secretase inhibitors: pharmacophore modeling, virtual screening, and docking studies.
Niu Y; Ma C; Jin H; Xu F; Gao H; Liu P; Li Y; Wang C; Yang G; Xu P
Chem Biol Drug Des; 2012 Jun; 79(6):972-80. PubMed ID: 22381116
[TBL] [Abstract][Full Text] [Related]
8. Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity.
Sarvagalla S; Singh VK; Ke YY; Shiao HY; Lin WH; Hsieh HP; Hsu JT; Coumar MS
J Comput Aided Mol Des; 2015 Jan; 29(1):89-100. PubMed ID: 25344840
[TBL] [Abstract][Full Text] [Related]
9. Design and Amberlyst-15 mediated synthesis of novel thienyl-pyrazole carboxamides that potently inhibit Phospholipase A2 by binding to an allosteric site on the enzyme.
Kumar AD; Prabhudeva MG; Bharath S; Kumara K; Lokanath NK; Kumar KA
Bioorg Chem; 2018 Oct; 80():444-452. PubMed ID: 29986189
[TBL] [Abstract][Full Text] [Related]
10. Lipidomics-based assays coupled with computational approaches can identify novel phospholipase A
Mouchlis VD; Mu C; Hammons R; Dennis EA
Adv Biol Regul; 2020 May; 76():100719. PubMed ID: 32199750
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design.
Duffy BC; Liu S; Martin GS; Wang R; Hsia MM; Zhao H; Guo C; Ellis M; Quinn JF; Kharenko OA; Norek K; Gesner EM; Young PR; McLure KG; Wagner GS; Lakshminarasimhan D; White A; Suto RK; Hansen HC; Kitchen DB
Bioorg Med Chem Lett; 2015 Jul; 25(14):2818-23. PubMed ID: 26022843
[TBL] [Abstract][Full Text] [Related]
12. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.
Beniyama Y; Matsuno K; Miyachi H
Bioorg Med Chem Lett; 2013 Mar; 23(6):1662-6. PubMed ID: 23395658
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based lead discovery: screening and optimizing fragments for thermolysin inhibition.
Englert L; Silber K; Steuber H; Brass S; Over B; Gerber HD; Heine A; Diederich WE; Klebe G
ChemMedChem; 2010 Jun; 5(6):930-40. PubMed ID: 20394106
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds.
Caballero J; Alzate-Morales JH; Vergara-Jaque A
J Chem Inf Model; 2011 Nov; 51(11):2920-31. PubMed ID: 22011048
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screening.
Ghattas MA; Atatreh N; Bichenkova EV; Bryce RA
J Mol Graph Model; 2014 Jul; 52():114-23. PubMed ID: 25038507
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel vascular endothelial growth factor receptor 2 inhibitors: a virtual screening approach.
Zhang L; Wang X; Feng J; Jia Y; Xu F; Xu W
Chem Biol Drug Des; 2012 Dec; 80(6):893-901. PubMed ID: 22913881
[TBL] [Abstract][Full Text] [Related]
19. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
Wang P; Li Y; Shao Q; Zhou W; Wang K
J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel potent human testis-specific and bromodomain-containing protein (BRDT) inhibitors using crystal structure-based virtual screening.
Gao N; Ren J; Hou L; Zhou Y; Xin L; Wang J; Yu H; Xie Y; Wang H
Int J Mol Med; 2016 Jul; 38(1):39-44. PubMed ID: 27220398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
